Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance - Top-Institutions - MDSpire

Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance

  • By

  • Molly Javier Uyeda

  • Audrey Re

  • Chunyi Tang

  • Melissa McLaughlin

  • Daryl Humes

  • Steven Sexton

  • Robert Freeborn

  • Isaura Villalba

  • Kevin Nugent

  • James Adams

  • Jie Wei

  • Matt Breton

  • Xavier Paliard

  • Maximilian Richter

  • Maria Grazia Roncarolo

  • Ryan Bjordahl

  • July 9, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Stanford University School of Medicine and Lucile Packard Children’s Hospital Stanford
    Stanford University School of Medicine and Lucile Packard Children’s Hospital Stanford

    Stanford, California

    Key Differentiators

    • Immunology
    • Cell and Gene Therapy

  • #2

    IRCCS Ospedale San Raffaele and San Raffaele Telethon Institute for Gene Therapy
    IRCCS Ospedale San Raffaele and San Raffaele Telethon Institute for Gene Therapy

    Milan, Italy

    Key Differentiators

    • Immunology
    • Gene Therapy

  • #3

    Baylor College of Medicine
    Baylor College of Medicine

    Houston, Texas

    Key Differentiators

    • Immunology
    • Cell and Gene Therapy

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Immunology
    • Cancer Care

  • #5

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Immunology
    • Medical Education

Original Source(s)

Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance

  • by Molly Javier Uyeda, Audrey Re, Chunyi Tang, Melissa McLaughlin, Daryl Humes, Steven Sexton, Robert Freeborn, Isaura Villalba, Kevin Nugent, James Adams, Jie Wei, Matt Breton, Xavier Paliard, Maximilian Richter, Maria Grazia Roncarolo, Ryan Bjordahl

  • July 9, 2026

Related Content

Editorial: Allo-HSCT: novel clinical applications and therapeutic strategies in adults and analysis of rare procedure complications

CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric antigen receptors

Systemic immune-inflammation Index is an independent risk factor for Major adverse cardiovascular events in patients with coronary artery ectasia